Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Whether toxicity might occur at somewhat lower doses is unknown
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP/GLP-1 receptor agonist that has transformed metabolic disease treatment
The cons are similar to those of Ozempic and Wegovy
First-line obesity treatments include lifestyle intervention (e.g., low-calorie diets) and behavioral modification therapies 4,5 since approved obesity medications have limited efficacy and commonly have side effects 6
Optimizing delivery systems is crucial for long-term obesity treatment and medication adherence
US$ 26.70
US$ 26.26
US$ 21.30
US$ 25.05
US$ 28.29
US$ 22.36
US$ 23.32
